Akèy › Maladi Alzheimer › Georgia
Etid klinik pou Maladi Alzheimer nan Georgia
24 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Augusta
- Clinical Site, Snellville
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- CenExeli Research LLC, Savannah
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2611, Atlanta
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Accel Research - NeuroStudies, Decatur
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Local Institution - 0004, Decatur
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 24, 2026 · NCT07780383A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Agile Clinical Research Trials, LLC, Atlanta
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Columbus Memory Center, Columbus
- Center for Advanced Research & Education Flourish-Gainesville, Gainsville
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Grady Memorial Hospital, Atlanta
- Alzheimer's Research and Treatment Center - Columbus, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- ak 2 plis
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Agile Clinical Research Trials, LLC, Atlanta
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- CenExel iResearch, LLC, Decatur
- CenExel iResearch, LLC, Savannah
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- CenExel iResearch, LLC ( Site 1015), Decatur
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel iResearch, LLC (CenExel iRA), Decatur
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Alzheimer's Research and Treatment Center (Columbus), Columbus
Ap rekriteFaz 1
Laj 65 a 80 · Tout sèks · Mizajou Aug 21, 2026 · NCT07158905A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Center for Advanced Research & Education, Gainesville
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Emory University School of Medicine, Atlanta
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157Moving Yourself in Space and Time: MYSTIC
- Emory University, Executive Park, Wesley Woods, Atlanta
Ap rekriteVolontè an sante akeyi
Laj 18 a 79 · Tout sèks · Mizajou Jul 13, 2026 · NCT07697664A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Center for Advanced Research & Education, Gainesville
- North Georgia Clinical Research, Woodstock
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Atlanta Center of Medical Research, Atlanta
- CenExel iResearch, LLC (CenExel iRA), Decatur
Ap rekriteFaz 1Volontè an sante akeyi
Laj 45 a 85 · Tout sèks · Mizajou Jun 4, 2026 · NCT06657768Inspiring Seniors Towards Exercise Promotion to Protect Cognition
- Emory University, Atlanta
Ap rekriteVolontè an sante akeyi
Laj 65 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT06496425Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- Emory Rehabilitation Hospital, Atlanta
Ap rekrite
Laj 50 a 90 · Tout sèks · Mizajou Mar 2, 2026 · NCT06484244Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Reminiscent, Valdosta
Ap rekrite
Laj 65 a 90 · Tout sèks · Mizajou Feb 4, 2026 · NCT05205980A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- Wellstar MCG Hospital, Neurology Memory Clinic, Augusta
Ap rekriteFaz 1
Laj 65 a 85 · Tout sèks · Mizajou Jan 7, 2026 · NCT07218081Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.